Stijn A. Peeters

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

Stijn A. Peeters, Lian Engelen, Jacqueline Buijs et al. · Cardiovascular Diabetology · 2015 · 69 citations · Full text

Veterinary Medicine, Internal Medicine, Diabetology +15

Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study

Stijn A. Peeters, Lian Engelen, J. Buijs et al. · Cardiovascular Diabetology · 2017 · 58 citations · Full text

Medicine, Internal Medicine, Aging +8

Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies

Stijn A. Peeters, Lian Engelen, Jacqueline Buijs et al. · Cardiovascular Diabetology · 2017 · 36 citations · Full text

Medicine, Internal Medicine, Clinical Cardiology +13

Is standardized cardiac assessment of asymptomatic high-risk renal transplant candidates beneficial?

Jeroen Aalten, Stijn A. Peeters, M. J. van der Vlugt et al. · Nephrology Dialysis Transplantation · 2011 · 21 citations

Medicine, Cardiology, Surgery +14

Associations between advanced glycation endproducts and matrix metalloproteinases and its inhibitor in individuals with type 1 diabetes

Stijn A. Peeters, Lian Engelen, J. Buijs et al. · Journal of Diabetes and its Complications · 2018 · 15 citations

Life Sciences, Biochemistry, Molecular Biology +16